Bristol-Myers, Gilead sales and marketing update

Massachusetts’ Medicaid agency MassHealth said it will make Gilead’s Harvoni ledipasvir/sofosbuvir its exclusive regimen to treat about 80% of HCV infections in exchange for an undisclosed rebate. Ma...